The global Omalizumab Biosimilars market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Omalizumab is a medication used to treat asthma, nasal polyps, and urticaria. Omalizumab is a recombinant DNA-derived humanized IgG1k monoclonal antibody that specifically binds to free human immunoglobulin E (IgE) in the blood and interstitial fluid and to membrane-bound form of IgE (mIgE) on the surface of mIgE-expressing B lymphocytes. Unlike an ordinary anti-IgE antibody, it does not bind to IgE that is already bound by the high affinity IgE receptor (FcRI) on the surface of mast cells, basophils, and antigen-presenting dendritic cells.
This report aims to provide a comprehensive presentation of the global market for Omalizumab Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Omalizumab Biosimilars. This report contains market size and forecasts of Omalizumab Biosimilars in global, including the following market information:
Global Omalizumab Biosimilars Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Omalizumab Biosimilars Market Sales, 2018-2023, 2024-2032, (Units)
Global top five Omalizumab Biosimilars companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
150 mg/mL Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Omalizumab Biosimilars include Roche, Novartis, Glenmark Pharmaceuticals, Selexis, Generium, CuraTeQ, Celltrion Healthcare, Alvotech and BiosanaPharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Omalizumab Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Omalizumab Biosimilars Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (Units)
Global Omalizumab Biosimilars Market Segment Percentages, by Type, 2022 (%)
Global Omalizumab Biosimilars Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (Units)
Global Omalizumab Biosimilars Market Segment Percentages, by Application, 2022 (%)
- Persistent Asthma
- Nasal Polyps
- Chronic Idiopathic Urticaria
Global Omalizumab Biosimilars Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (Units)
Global Omalizumab Biosimilars Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Omalizumab Biosimilars revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Omalizumab Biosimilars revenues share in global market, 2022 (%)
- Key companies Omalizumab Biosimilars sales in global market, 2018-2023 (Estimated), (Units)
- Key companies Omalizumab Biosimilars sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche
- Novartis
- Glenmark Pharmaceuticals
- Selexis
- Generium
- CuraTeQ
- Celltrion Healthcare
- Alvotech
- BiosanaPharma
- Mabpharm
- CSPC Pharmaceutical Group
- Biomabs
- HisunPharm
- Grand Pharm
Outline of Major Chapters:
Chapter 1: Introduces the definition of Omalizumab Biosimilars, market overview.
Chapter 2: Global Omalizumab Biosimilars market size in revenue and volume.
Chapter 3: Detailed analysis of Omalizumab Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Omalizumab Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Omalizumab Biosimilars capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Omalizumab Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Omalizumab Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Omalizumab Biosimilars Overall Market Size
2.1 Global Omalizumab Biosimilars Market Size: 2022 VS 2032
2.2 Global Omalizumab Biosimilars Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Omalizumab Biosimilars Sales: 2018-2032
3 Company Landscape
3.1 Top Omalizumab Biosimilars Players in Global Market
3.2 Top Global Omalizumab Biosimilars Companies Ranked by Revenue
3.3 Global Omalizumab Biosimilars Revenue by Companies
3.4 Global Omalizumab Biosimilars Sales by Companies
3.5 Global Omalizumab Biosimilars Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Omalizumab Biosimilars Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Omalizumab Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Omalizumab Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Omalizumab Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Omalizumab Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Omalizumab Biosimilars Market Size Markets, 2022 & 2032
4.1.2 150 mg/mL
4.1.3 75 mg/0.5 mL
4.2 By Type - Global Omalizumab Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Omalizumab Biosimilars Revenue, 2018-2023
4.2.2 By Type - Global Omalizumab Biosimilars Revenue, 2024-2032
4.2.3 By Type - Global Omalizumab Biosimilars Revenue Market Share, 2018-2032
4.3 By Type - Global Omalizumab Biosimilars Sales & Forecasts
4.3.1 By Type - Global Omalizumab Biosimilars Sales, 2018-2023
4.3.2 By Type - Global Omalizumab Biosimilars Sales, 2024-2032
4.3.3 By Type - Global Omalizumab Biosimilars Sales Market Share, 2018-2032
4.4 By Type - Global Omalizumab Biosimilars Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Omalizumab Biosimilars Market Size, 2022 & 2032
5.1.2 Persistent Asthma
5.1.3 Nasal Polyps
5.1.4 Chronic Idiopathic Urticaria
5.2 By Application - Global Omalizumab Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Omalizumab Biosimilars Revenue, 2018-2023
5.2.2 By Application - Global Omalizumab Biosimilars Revenue, 2024-2032
5.2.3 By Application - Global Omalizumab Biosimilars Revenue Market Share, 2018-2032
5.3 By Application - Global Omalizumab Biosimilars Sales & Forecasts
5.3.1 By Application - Global Omalizumab Biosimilars Sales, 2018-2023
5.3.2 By Application - Global Omalizumab Biosimilars Sales, 2024-2032
5.3.3 By Application - Global Omalizumab Biosimilars Sales Market Share, 2018-2032
5.4 By Application - Global Omalizumab Biosimilars Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Omalizumab Biosimilars Market Size, 2022 & 2032
6.2 By Region - Global Omalizumab Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Omalizumab Biosimilars Revenue, 2018-2023
6.2.2 By Region - Global Omalizumab Biosimilars Revenue, 2024-2032
6.2.3 By Region - Global Omalizumab Biosimilars Revenue Market Share, 2018-2032
6.3 By Region - Global Omalizumab Biosimilars Sales & Forecasts
6.3.1 By Region - Global Omalizumab Biosimilars Sales, 2018-2023
6.3.2 By Region - Global Omalizumab Biosimilars Sales, 2024-2032
6.3.3 By Region - Global Omalizumab Biosimilars Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Omalizumab Biosimilars Revenue, 2018-2032
6.4.2 By Country - North America Omalizumab Biosimilars Sales, 2018-2032
6.4.3 US Omalizumab Biosimilars Market Size, 2018-2032
6.4.4 Canada Omalizumab Biosimilars Market Size, 2018-2032
6.4.5 Mexico Omalizumab Biosimilars Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Omalizumab Biosimilars Revenue, 2018-2032
6.5.2 By Country - Europe Omalizumab Biosimilars Sales, 2018-2032
6.5.3 Germany Omalizumab Biosimilars Market Size, 2018-2032
6.5.4 France Omalizumab Biosimilars Market Size, 2018-2032
6.5.5 U.K. Omalizumab Biosimilars Market Size, 2018-2032
6.5.6 Italy Omalizumab Biosimilars Market Size, 2018-2032
6.5.7 Russia Omalizumab Biosimilars Market Size, 2018-2032
6.5.8 Nordic Countries Omalizumab Biosimilars Market Size, 2018-2032
6.5.9 Benelux Omalizumab Biosimilars Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Omalizumab Biosimilars Revenue, 2018-2032
6.6.2 By Region - Asia Omalizumab Biosimilars Sales, 2018-2032
6.6.3 China Omalizumab Biosimilars Market Size, 2018-2032
6.6.4 Japan Omalizumab Biosimilars Market Size, 2018-2032
6.6.5 South Korea Omalizumab Biosimilars Market Size, 2018-2032
6.6.6 Southeast Asia Omalizumab Biosimilars Market Size, 2018-2032
6.6.7 India Omalizumab Biosimilars Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Omalizumab Biosimilars Revenue, 2018-2032
6.7.2 By Country - South America Omalizumab Biosimilars Sales, 2018-2032
6.7.3 Brazil Omalizumab Biosimilars Market Size, 2018-2032
6.7.4 Argentina Omalizumab Biosimilars Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Omalizumab Biosimilars Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Omalizumab Biosimilars Sales, 2018-2032
6.8.3 Turkey Omalizumab Biosimilars Market Size, 2018-2032
6.8.4 Israel Omalizumab Biosimilars Market Size, 2018-2032
6.8.5 Saudi Arabia Omalizumab Biosimilars Market Size, 2018-2032
6.8.6 UAE Omalizumab Biosimilars Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Omalizumab Biosimilars Major Product Offerings
7.1.4 Roche Omalizumab Biosimilars Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Omalizumab Biosimilars Major Product Offerings
7.2.4 Novartis Omalizumab Biosimilars Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Glenmark Pharmaceuticals
7.3.1 Glenmark Pharmaceuticals Company Summary
7.3.2 Glenmark Pharmaceuticals Business Overview
7.3.3 Glenmark Pharmaceuticals Omalizumab Biosimilars Major Product Offerings
7.3.4 Glenmark Pharmaceuticals Omalizumab Biosimilars Sales and Revenue in Global (2018-2023)
7.3.5 Glenmark Pharmaceuticals Key News & Latest Developments
7.4 Selexis
7.4.1 Selexis Company Summary
7.4.2 Selexis Business Overview
7.4.3 Selexis Omalizumab Biosimilars Major Product Offerings
7.4.4 Selexis Omalizumab Biosimilars Sales and Revenue in Global (2018-2023)
7.4.5 Selexis Key News & Latest Developments
7.5 Generium
7.5.1 Generium Company Summary
7.5.2 Generium Business Overview
7.5.3 Generium Omalizumab Biosimilars Major Product Offerings
7.5.4 Generium Omalizumab Biosimilars Sales and Revenue in Global (2018-2023)
7.5.5 Generium Key News & Latest Developments
7.6 CuraTeQ
7.6.1 CuraTeQ Company Summary
7.6.2 CuraTeQ Business Overview
7.6.3 CuraTeQ Omalizumab Biosimilars Major Product Offerings
7.6.4 CuraTeQ Omalizumab Biosimilars Sales and Revenue in Global (2018-2023)
7.6.5 CuraTeQ Key News & Latest Developments
7.7 Celltrion Healthcare
7.7.1 Celltrion Healthcare Company Summary
7.7.2 Celltrion Healthcare Business Overview
7.7.3 Celltrion Healthcare Omalizumab Biosimilars Major Product Offerings
7.7.4 Celltrion Healthcare Omalizumab Biosimilars Sales and Revenue in Global (2018-2023)
7.7.5 Celltrion Healthcare Key News & Latest Developments
7.8 Alvotech
7.8.1 Alvotech Company Summary
7.8.2 Alvotech Business Overview
7.8.3 Alvotech Omalizumab Biosimilars Major Product Offerings
7.8.4 Alvotech Omalizumab Biosimilars Sales and Revenue in Global (2018-2023)
7.8.5 Alvotech Key News & Latest Developments
7.9 BiosanaPharma
7.9.1 BiosanaPharma Company Summary
7.9.2 BiosanaPharma Business Overview
7.9.3 BiosanaPharma Omalizumab Biosimilars Major Product Offerings
7.9.4 BiosanaPharma Omalizumab Biosimilars Sales and Revenue in Global (2018-2023)
7.9.5 BiosanaPharma Key News & Latest Developments
7.10 Mabpharm
7.10.1 Mabpharm Company Summary
7.10.2 Mabpharm Business Overview
7.10.3 Mabpharm Omalizumab Biosimilars Major Product Offerings
7.10.4 Mabpharm Omalizumab Biosimilars Sales and Revenue in Global (2018-2023)
7.10.5 Mabpharm Key News & Latest Developments
7.11 CSPC Pharmaceutical Group
7.11.1 CSPC Pharmaceutical Group Company Summary
7.11.2 CSPC Pharmaceutical Group Omalizumab Biosimilars Business Overview
7.11.3 CSPC Pharmaceutical Group Omalizumab Biosimilars Major Product Offerings
7.11.4 CSPC Pharmaceutical Group Omalizumab Biosimilars Sales and Revenue in Global (2018-2023)
7.11.5 CSPC Pharmaceutical Group Key News & Latest Developments
7.12 Biomabs
7.12.1 Biomabs Company Summary
7.12.2 Biomabs Omalizumab Biosimilars Business Overview
7.12.3 Biomabs Omalizumab Biosimilars Major Product Offerings
7.12.4 Biomabs Omalizumab Biosimilars Sales and Revenue in Global (2018-2023)
7.12.5 Biomabs Key News & Latest Developments
7.13 HisunPharm
7.13.1 HisunPharm Company Summary
7.13.2 HisunPharm Omalizumab Biosimilars Business Overview
7.13.3 HisunPharm Omalizumab Biosimilars Major Product Offerings
7.13.4 HisunPharm Omalizumab Biosimilars Sales and Revenue in Global (2018-2023)
7.13.5 HisunPharm Key News & Latest Developments
7.14 Grand Pharm
7.14.1 Grand Pharm Company Summary
7.14.2 Grand Pharm Business Overview
7.14.3 Grand Pharm Omalizumab Biosimilars Major Product Offerings
7.14.4 Grand Pharm Omalizumab Biosimilars Sales and Revenue in Global (2018-2023)
7.14.5 Grand Pharm Key News & Latest Developments
8 Global Omalizumab Biosimilars Production Capacity, Analysis
8.1 Global Omalizumab Biosimilars Production Capacity, 2018-2032
8.2 Omalizumab Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Omalizumab Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Omalizumab Biosimilars Supply Chain Analysis
10.1 Omalizumab Biosimilars Industry Value Chain
10.2 Omalizumab Biosimilars Upstream Market
10.3 Omalizumab Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Omalizumab Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Omalizumab Biosimilars in Global Market
Table 2. Top Omalizumab Biosimilars Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Omalizumab Biosimilars Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Omalizumab Biosimilars Revenue Share by Companies, 2018-2023
Table 5. Global Omalizumab Biosimilars Sales by Companies, (Units), 2018-2023
Table 6. Global Omalizumab Biosimilars Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Omalizumab Biosimilars Price (2018-2023) & (K USD/Unit)
Table 8. Global Manufacturers Omalizumab Biosimilars Product Type
Table 9. List of Global Tier 1 Omalizumab Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Omalizumab Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Omalizumab Biosimilars Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Omalizumab Biosimilars Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Omalizumab Biosimilars Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Omalizumab Biosimilars Sales (Units), 2018-2023
Table 15. By Type - Global Omalizumab Biosimilars Sales (Units), 2024-2032
Table 16. By Application ? Global Omalizumab Biosimilars Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Omalizumab Biosimilars Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Omalizumab Biosimilars Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Omalizumab Biosimilars Sales (Units), 2018-2023
Table 20. By Application - Global Omalizumab Biosimilars Sales (Units), 2024-2032
Table 21. By Region ? Global Omalizumab Biosimilars Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Omalizumab Biosimilars Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Omalizumab Biosimilars Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Omalizumab Biosimilars Sales (Units), 2018-2023
Table 25. By Region - Global Omalizumab Biosimilars Sales (Units), 2024-2032
Table 26. By Country - North America Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Omalizumab Biosimilars Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Omalizumab Biosimilars Sales, (Units), 2018-2023
Table 29. By Country - North America Omalizumab Biosimilars Sales, (Units), 2024-2032
Table 30. By Country - Europe Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Omalizumab Biosimilars Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Omalizumab Biosimilars Sales, (Units), 2018-2023
Table 33. By Country - Europe Omalizumab Biosimilars Sales, (Units), 2024-2032
Table 34. By Region - Asia Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Omalizumab Biosimilars Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Omalizumab Biosimilars Sales, (Units), 2018-2023
Table 37. By Region - Asia Omalizumab Biosimilars Sales, (Units), 2024-2032
Table 38. By Country - South America Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Omalizumab Biosimilars Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Omalizumab Biosimilars Sales, (Units), 2018-2023
Table 41. By Country - South America Omalizumab Biosimilars Sales, (Units), 2024-2032
Table 42. By Country - Middle East & Africa Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Omalizumab Biosimilars Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Omalizumab Biosimilars Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Omalizumab Biosimilars Sales, (Units), 2024-2032
Table 46. Roche Company Summary
Table 47. Roche Omalizumab Biosimilars Product Offerings
Table 48. Roche Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Omalizumab Biosimilars Product Offerings
Table 52. Novartis Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Glenmark Pharmaceuticals Company Summary
Table 55. Glenmark Pharmaceuticals Omalizumab Biosimilars Product Offerings
Table 56. Glenmark Pharmaceuticals Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 57. Glenmark Pharmaceuticals Key News & Latest Developments
Table 58. Selexis Company Summary
Table 59. Selexis Omalizumab Biosimilars Product Offerings
Table 60. Selexis Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 61. Selexis Key News & Latest Developments
Table 62. Generium Company Summary
Table 63. Generium Omalizumab Biosimilars Product Offerings
Table 64. Generium Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 65. Generium Key News & Latest Developments
Table 66. CuraTeQ Company Summary
Table 67. CuraTeQ Omalizumab Biosimilars Product Offerings
Table 68. CuraTeQ Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 69. CuraTeQ Key News & Latest Developments
Table 70. Celltrion Healthcare Company Summary
Table 71. Celltrion Healthcare Omalizumab Biosimilars Product Offerings
Table 72. Celltrion Healthcare Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 73. Celltrion Healthcare Key News & Latest Developments
Table 74. Alvotech Company Summary
Table 75. Alvotech Omalizumab Biosimilars Product Offerings
Table 76. Alvotech Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 77. Alvotech Key News & Latest Developments
Table 78. BiosanaPharma Company Summary
Table 79. BiosanaPharma Omalizumab Biosimilars Product Offerings
Table 80. BiosanaPharma Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 81. BiosanaPharma Key News & Latest Developments
Table 82. Mabpharm Company Summary
Table 83. Mabpharm Omalizumab Biosimilars Product Offerings
Table 84. Mabpharm Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 85. Mabpharm Key News & Latest Developments
Table 86. CSPC Pharmaceutical Group Company Summary
Table 87. CSPC Pharmaceutical Group Omalizumab Biosimilars Product Offerings
Table 88. CSPC Pharmaceutical Group Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 89. CSPC Pharmaceutical Group Key News & Latest Developments
Table 90. Biomabs Company Summary
Table 91. Biomabs Omalizumab Biosimilars Product Offerings
Table 92. Biomabs Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 93. Biomabs Key News & Latest Developments
Table 94. HisunPharm Company Summary
Table 95. HisunPharm Omalizumab Biosimilars Product Offerings
Table 96. HisunPharm Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 97. HisunPharm Key News & Latest Developments
Table 98. Grand Pharm Company Summary
Table 99. Grand Pharm Omalizumab Biosimilars Product Offerings
Table 100. Grand Pharm Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 101. Grand Pharm Key News & Latest Developments
Table 102. Omalizumab Biosimilars Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 103. Global Omalizumab Biosimilars Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Omalizumab Biosimilars Production by Region, 2018-2023 (Units)
Table 105. Global Omalizumab Biosimilars Production by Region, 2024-2032 (Units)
Table 106. Omalizumab Biosimilars Market Opportunities & Trends in Global Market
Table 107. Omalizumab Biosimilars Market Drivers in Global Market
Table 108. Omalizumab Biosimilars Market Restraints in Global Market
Table 109. Omalizumab Biosimilars Raw Materials
Table 110. Omalizumab Biosimilars Raw Materials Suppliers in Global Market
Table 111. Typical Omalizumab Biosimilars Downstream
Table 112. Omalizumab Biosimilars Downstream Clients in Global Market
Table 113. Omalizumab Biosimilars Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Omalizumab Biosimilars Segment by Type in 2022
Figure 2. Omalizumab Biosimilars Segment by Application in 2022
Figure 3. Global Omalizumab Biosimilars Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Omalizumab Biosimilars Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Omalizumab Biosimilars Revenue, 2018-2032 (US$, Mn)
Figure 7. Omalizumab Biosimilars Sales in Global Market: 2018-2032 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Omalizumab Biosimilars Revenue in 2022
Figure 9. By Type - Global Omalizumab Biosimilars Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Omalizumab Biosimilars Revenue Market Share, 2018-2032
Figure 11. By Type - Global Omalizumab Biosimilars Sales Market Share, 2018-2032
Figure 12. By Type - Global Omalizumab Biosimilars Price (K USD/Unit), 2018-2032
Figure 13. By Application - Global Omalizumab Biosimilars Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Omalizumab Biosimilars Revenue Market Share, 2018-2032
Figure 15. By Application - Global Omalizumab Biosimilars Sales Market Share, 2018-2032
Figure 16. By Application - Global Omalizumab Biosimilars Price (K USD/Unit), 2018-2032
Figure 17. By Region - Global Omalizumab Biosimilars Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Omalizumab Biosimilars Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Omalizumab Biosimilars Revenue Market Share, 2018-2032
Figure 20. By Region - Global Omalizumab Biosimilars Sales Market Share, 2018-2032
Figure 21. By Country - North America Omalizumab Biosimilars Revenue Market Share, 2018-2032
Figure 22. By Country - North America Omalizumab Biosimilars Sales Market Share, 2018-2032
Figure 23. US Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Omalizumab Biosimilars Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Omalizumab Biosimilars Sales Market Share, 2018-2032
Figure 28. Germany Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 29. France Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Omalizumab Biosimilars Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Omalizumab Biosimilars Sales Market Share, 2018-2032
Figure 37. China Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 41. India Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Omalizumab Biosimilars Revenue Market Share, 2018-2032
Figure 43. By Country - South America Omalizumab Biosimilars Sales Market Share, 2018-2032
Figure 44. Brazil Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Omalizumab Biosimilars Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Omalizumab Biosimilars Sales Market Share, 2018-2032
Figure 48. Turkey Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Omalizumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 52. Global Omalizumab Biosimilars Production Capacity (Units), 2018-2032
Figure 53. The Percentage of Production Omalizumab Biosimilars by Region, 2022 VS 2032
Figure 54. Omalizumab Biosimilars Industry Value Chain
Figure 55. Marketing Channels
